NEW YORK (GenomeWeb News) – CombiMatrix today announced a 13 percent spike in first quarter revenues, driven by a 34 percent jump in sales generated by its prenatal chromosomal microarray analysis testing services.

The Irvine, Calif.-based molecular diagnostics company said that total revenues for the three months ended March 31 increased to $1.8 million from $1.6 million in the first quarter of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.